Differing impact of the COVID-19 pandemic on youth mental health: combined population and clinical study.

COVID-19 adolescent alcohol use disorder depression eating disorders

Journal

BJPsych open
ISSN: 2056-4724
Titre abrégé: BJPsych Open
Pays: England
ID NLM: 101667931

Informations de publication

Date de publication:
20 Nov 2023
Historique:
medline: 20 11 2023
pubmed: 20 11 2023
entrez: 19 11 2023
Statut: epublish

Résumé

Identifying youths most at risk to COVID-19-related mental illness is essential for the development of effective targeted interventions. To compare trajectories of mental health throughout the pandemic in youth with and without prior mental illness and identify those most at risk of COVID-19-related mental illness. Data were collected from individuals aged 18-26 years ( Mental health trajectories differed significantly between cohorts. In the population cohort, depression and eating disorder symptoms increased by 33.9% (95% CI 31.78-36.57) and 15.6% (95% CI 15.39-15.68) during the pandemic, respectively. By contrast, these remained high over time in the clinical cohort. Conversely, trajectories of alcohol misuse were similar in both cohorts, decreasing continuously (a 15.2% decrease) during the pandemic. Pre-pandemic symptom severity predicted the observed mental health trajectories in the population cohort. Surprisingly, being relatively healthy predicted increases in depression and eating disorder symptoms and in body mass index. By contrast, those initially at higher risk for depression or eating disorders reported a lasting decrease. Healthier young people may be at greater risk of developing depressive or eating disorder symptoms during the COVID-19 pandemic. Targeted mental health interventions considering prior diagnostic risk may be warranted to help young people cope with the challenges of psychosocial stress and reduce the associated healthcare burden.

Sections du résumé

BACKGROUND BACKGROUND
Identifying youths most at risk to COVID-19-related mental illness is essential for the development of effective targeted interventions.
AIMS OBJECTIVE
To compare trajectories of mental health throughout the pandemic in youth with and without prior mental illness and identify those most at risk of COVID-19-related mental illness.
METHOD METHODS
Data were collected from individuals aged 18-26 years (
RESULTS RESULTS
Mental health trajectories differed significantly between cohorts. In the population cohort, depression and eating disorder symptoms increased by 33.9% (95% CI 31.78-36.57) and 15.6% (95% CI 15.39-15.68) during the pandemic, respectively. By contrast, these remained high over time in the clinical cohort. Conversely, trajectories of alcohol misuse were similar in both cohorts, decreasing continuously (a 15.2% decrease) during the pandemic. Pre-pandemic symptom severity predicted the observed mental health trajectories in the population cohort. Surprisingly, being relatively healthy predicted increases in depression and eating disorder symptoms and in body mass index. By contrast, those initially at higher risk for depression or eating disorders reported a lasting decrease.
CONCLUSIONS CONCLUSIONS
Healthier young people may be at greater risk of developing depressive or eating disorder symptoms during the COVID-19 pandemic. Targeted mental health interventions considering prior diagnostic risk may be warranted to help young people cope with the challenges of psychosocial stress and reduce the associated healthcare burden.

Identifiants

pubmed: 37981567
doi: 10.1192/bjo.2023.601
pii: S2056472423006014
pmc: PMC10753963
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e217

Subventions

Organisme : MRF
ID : MR/N000390/1
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-058-0004-RG-DESRI
Pays : United Kingdom
Organisme : MRF
ID : MR/W002418/1
Pays : United Kingdom
Organisme : MRF
ID : MRF-058-0014-F-ZHAN-C0866
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG058854
Pays : United States
Organisme : Medical Research Council
ID : MR/W002418/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : 1R56AG058854-02-'ENIGMA World Aging Center'
Pays : United States
Organisme : Medical Research Council
ID : MR/S020306/1
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-058-0009-RG-DESR-C0759
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R01 DA049238
Pays : United States
Organisme : Medical Research Council
ID : MR/R00465X/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH085772
Pays : United States

Références

Int J Eat Disord. 1994 Dec;16(4):363-70
pubmed: 7866415
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
JAMA Pediatr. 2021 Nov 1;175(11):1142-1150
pubmed: 34369987
BJPsych Open. 2022 Mar 07;8(2):e59
pubmed: 35249586
J Am Acad Child Adolesc Psychiatry. 2022 Nov;61(11):1341-1350
pubmed: 35452785
J Affect Disord. 2021 Oct 1;293:78-89
pubmed: 34174475
J Affect Disord. 2021 Nov 1;294:479-480
pubmed: 34330041
Int J Eat Disord. 2023 Jan;56(1):5-25
pubmed: 35384016
Lancet Psychiatry. 2021 Feb;8(2):121-129
pubmed: 33306975
Psychiatry Res. 2020 Dec;294:113493
pubmed: 33038789
Lancet Psychiatry. 2021 Feb;8(2):141-149
pubmed: 33308420
Curr Psychiatry Rep. 2022 Jun;24(6):307-324
pubmed: 35476186
Lancet Public Health. 2022 May;7(5):e417-e426
pubmed: 35461592
JAMA Netw Open. 2022 Aug 1;5(8):e2224641
pubmed: 35913741
BMC Public Health. 2022 Aug 5;22(1):1495
pubmed: 35932040
Behav Res Ther. 2008 May;46(5):612-22
pubmed: 18359005
Can J Psychiatry. 2022 Nov;67(11):841-853
pubmed: 35635281
Sci Rep. 2021 Apr 14;11(1):8139
pubmed: 33854103
J Affect Disord. 2021 Sep 1;292:398-404
pubmed: 34139414
Int J Eat Disord. 2023 Jan;56(1):269-275
pubmed: 36271511
Psychol Assess. 2000 Jun;12(2):123-31
pubmed: 10887758
JAMA Pediatr. 2022 Feb 1;176(2):205-206
pubmed: 34779861
Lancet Child Adolesc Health. 2020 Jun;4(6):421
pubmed: 32302537
Am J Geriatr Psychiatry. 2020 Sep;28(9):924-932
pubmed: 32682619
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Int J Eat Disord. 2018 Dec;51(12):1357-1360
pubmed: 30480321
J Eat Disord. 2021 Dec 3;9(1):155
pubmed: 34861897
Mol Psychiatry. 2010 Dec;15(12):1128-39
pubmed: 21102431
BMJ. 1997 Feb 8;314(7078):420-4
pubmed: 9040389
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Lancet Child Adolesc Health. 2018 Mar;2(3):223-228
pubmed: 30169257
Psychiatry Res. 2020 Nov;293:113486
pubmed: 33007682
Int J Environ Res Public Health. 2021 Jan 28;18(3):
pubmed: 33525740
Psychiatry Res. 2020 Aug;290:113143
pubmed: 32502829

Auteurs

Lu Qi (L)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Zuo Zhang (Z)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Lauren Robinson (L)

Department of Psychological Medicine, Section for Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; and South London and Maudsley NHS Foundation Trust, London, UK.

Marina Bobou (M)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Chantal Gourlan (C)

Institut National de la Santé et de la Recherche Médicale (INSERM) Research Unit 1299 'Trajectoires développementales en psychiatrie', Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.

Jeanne Winterer (J)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany; and Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany.

Rebecca Adams (R)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Kofoworola Agunbiade (K)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Yuning Zhang (Y)

Psychology Department, University of Southampton, Southampton, UK.

Sinead King (S)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; and School of Medicine, Center for Neuroimaging, Cognition and Genomics, National University of Ireland, Galway, Ireland.

Nilakshi Vaidya (N)

Centre for Population Neuroscience and Stratified Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany.

Eric Artiges (E)

Institut National de la Santé et de la Recherche Médicale Research Unit 1299 'Trajectoires développementales en psychiatrie', Ecole Normale Supérieure Paris-Saclay, Université Paris-Saclay, CentreNational de la Recherche Scientifique 9010, Centre Borelli, Gif-sur-Yvette, France; and Department of Psychiatry, Etablissement Public de Santé Barthélemy Durand, Etampes, France.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

M John Broulidakis (MJ)

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; and Department of Psychology, College of Science, Northeastern University, Boston, USA.

Rüdiger Brühl (R)

Physikalisch-Technische Bundesanstalt, Braunschweig, Berlin, Germany.

Herta Flor (H)

Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; and Department of Psychology, School of Social Sciences, University of Mannheim, Mannheim, Germany.

Juliane H Fröhner (JH)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Hugh Garavan (H)

Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont, USA.

Antoine Grigis (A)

NeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Sarah Hohmann (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Marie-Laure Paillère Martinot (MP)

Institut National de la Santé et de la Recherche Médicale Research Unit 1299 'Trajectoires développementales en psychiatrie', Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France; and Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.

Sabina Millenet (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Frauke Nees (F)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; and Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig-Holstein, Kiel University, Kiel, Germany.

Betteke Maria van Noort (BM)

Department of Psychology, MSB Medical School Berlin, Berlin, Germany.

Dimitri Papadopoulos Orfanos (DP)

Dimitri Papadopoulos Orfanos, NeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Göttingen, Germany.

Julia Sinclair (J)

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Argyris Stringaris (A)

Division of Psychiatry and Department of Clinical, Educational & Health Psychology, University College London, London, UK.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale Research Unit 1299 'Trajectoires développementales en psychiatrie', Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.

Gunter Schumann (G)

Centre for Population Neuroscience and Stratified Medicine, Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany; and Institut National de la Santé et de la Recherche Médicale Research Unit 1299 'Trajectoires développementales en psychiatrie', Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.

Ulrike Schmidt (U)

Institut National de la Santé et de la Recherche Médicale (INSERM) Research Unit 1299 'Trajectoires développementales en psychiatrie', Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.

Sylvane Desrivières (S)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Classifications MeSH